← Back to Search

Virtual Education Program for Atrial Fibrillation

N/A
Waitlist Available
Led By Anil Gehi, MD
Research Sponsored by University of North Carolina, Chapel Hill
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1-year prior to intervention session 1 and 1-year post intervention session 12
Awards & highlights
No Placebo-Only Group

Summary

This trial will assess the effectiveness of a virtual education program to help primary care providers better manage patients with AF.

Who is the study for?
This trial is for primary care providers (Physicians, Nurse Practitioners, Physician Assistants) who are based in North Carolina and manage adult patients with atrial fibrillation. There are no specific exclusion criteria mentioned, so it appears open to all eligible healthcare professionals within the state.
What is being tested?
The study tests a virtual education program called 'AF and EKG Interpretation Project ECHO' designed to improve knowledge and confidence among primary care providers managing atrial fibrillation. It involves 12 hours of Zoom sessions over twelve weeks and assessments before and after the program.
What are the potential side effects?
Since this trial focuses on an educational program rather than a medical intervention, there are no direct side effects associated with medications or treatments. However, participants may experience fatigue or eye strain from screen time.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1-year prior to intervention session 1 and 1-year post intervention session 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1-year prior to intervention session 1 and 1-year post intervention session 12 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Number of Patients Prescribed Appropriate Anticoagulation
Secondary study objectives
Change Score on Provider Knowledge Assessment
Change in Number of Emergency Department Visits or Hospitalizations for AF or Stroke
Change in Number of Patients Prescribed Appropriate Antiplatelet Therapy
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: AF and EKG Interpretation Project ECHOExperimental Treatment1 Intervention
All recruited participants participate in the AF and EKG Interpretation Project ECHO educational intervention.

Find a Location

Who is running the clinical trial?

Wake Forest UniversityOTHER
191 Previous Clinical Trials
164,951 Total Patients Enrolled
1 Trials studying Atrial Fibrillation
300 Patients Enrolled for Atrial Fibrillation
University of North Carolina, Chapel HillLead Sponsor
1,554 Previous Clinical Trials
4,293,008 Total Patients Enrolled
3 Trials studying Atrial Fibrillation
935 Patients Enrolled for Atrial Fibrillation
Duke UniversityOTHER
2,451 Previous Clinical Trials
2,971,639 Total Patients Enrolled
13 Trials studying Atrial Fibrillation
13,201 Patients Enrolled for Atrial Fibrillation

Media Library

AF and EKG Interpretation Project ECHO Clinical Trial Eligibility Overview. Trial Name: NCT05890274 — N/A
Atrial Fibrillation Research Study Groups: AF and EKG Interpretation Project ECHO
Atrial Fibrillation Clinical Trial 2023: AF and EKG Interpretation Project ECHO Highlights & Side Effects. Trial Name: NCT05890274 — N/A
AF and EKG Interpretation Project ECHO 2023 Treatment Timeline for Medical Study. Trial Name: NCT05890274 — N/A
~16 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top